Healthcare Stocks Deserve a Second Opinion

Healthcare stocks are due for a recovery. Despite strong fundamentals and innovation, the sector has lagged due to investor focus on AI beneficiaries and policy concerns. These concerns are now largely behind us.

Demographic trends, including an aging global population, will continue to drive demand for healthcare services and products. Innovation across pharmaceuticals, devices, and diagnostics is also creating new growth avenues. AI adoption could further accelerate earnings growth for early adopters.

The sector offers diversification away from AI-centric trades and attractive valuations. Investors should seek quality companies with resilient business models, as historical data shows healthcare outperforming in both rising and falling markets.